Macquarie Group Ltd. Buys 361,970 Shares of DENTSPLY SIRONA Inc (XRAY)

Macquarie Group Ltd. grew its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 17.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,439,248 shares of the medical instruments supplier’s stock after acquiring an additional 361,970 shares during the period. Macquarie Group Ltd. owned 1.06% of DENTSPLY SIRONA worth $160,725,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of XRAY. NuWave Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth $121,000. Massey Quick Simon & CO. LLC purchased a new stake in shares of DENTSPLY SIRONA during the third quarter worth $124,000. First Interstate Bank purchased a new stake in shares of DENTSPLY SIRONA during the third quarter worth $164,000. Focused Wealth Management Inc lifted its position in shares of DENTSPLY SIRONA by 79.2% during the fourth quarter. Focused Wealth Management Inc now owns 2,600 shares of the medical instruments supplier’s stock worth $171,000 after acquiring an additional 1,149 shares in the last quarter. Finally, Stock Yards Bank & Trust Co. purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth $203,000. Hedge funds and other institutional investors own 96.80% of the company’s stock.

In related news, Director Eric Brandt sold 6,409 shares of the stock in a transaction on Monday, January 8th. The stock was sold at an average price of $68.04, for a total value of $436,068.36. Following the transaction, the director now owns 12,073 shares of the company’s stock, valued at $821,446.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.99% of the stock is owned by corporate insiders.

Several equities research analysts have issued reports on the company. HC Wainwright set a $63.00 target price on DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Monday, March 5th. Barclays started coverage on DENTSPLY SIRONA in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $62.00 price objective on the stock. Barrington Research reiterated an “outperform” rating and issued a $70.00 price objective (down previously from $73.00) on shares of DENTSPLY SIRONA in a research report on Monday, March 5th. BidaskClub downgraded DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, February 28th. Finally, JPMorgan Chase & Co. lowered their price objective on DENTSPLY SIRONA from $75.00 to $70.00 and set an “overweight” rating on the stock in a research report on Monday, March 5th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $67.43.

DENTSPLY SIRONA Inc (XRAY) traded up $0.03 on Thursday, reaching $57.33. The company had a trading volume of 93,535 shares, compared to its average volume of 2,336,138. The company has a market capitalization of $13,275.67, a PE ratio of 21.73, a PEG ratio of 2.52 and a beta of 1.21. The company has a current ratio of 2.12, a quick ratio of 1.46 and a debt-to-equity ratio of 0.24. DENTSPLY SIRONA Inc has a 1-year low of $52.53 and a 1-year high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 EPS for the quarter, beating the Zacks’ consensus estimate of $0.81 by $0.01. The business had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.06 billion. DENTSPLY SIRONA had a positive return on equity of 8.35% and a negative net margin of 39.39%. The firm’s revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.67 earnings per share. equities research analysts predict that DENTSPLY SIRONA Inc will post 2.74 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be paid a $0.0875 dividend. The ex-dividend date is Wednesday, March 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio is presently -5.09%.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at


DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.

Leave a Reply